Cincinnati Drugmaker Cited for Quality, Equipment Concerns By Sam | April 26, 2019 The FDA hit Patheon Pharmaceuticals with a Form 483 for equipment and quality violations at its Cincinnati, Ohio facility. Source: Drug Industry Daily Posted in Drug Industry Daily